Gene Symbol | Gene ID | Gene Info |
---|---|---|
Otx1
|
ENSMUSG00000005917.9 | orthodenticle homeobox 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr11_22006485_22009037 | Otx1 | 4864 | 0.283289 | 0.61 | 2.9e-07 | Click! |
chr11_21995570_21998947 | Otx1 | 4357 | 0.283156 | 0.57 | 1.9e-06 | Click! |
chr11_21999153_21999972 | Otx1 | 2053 | 0.400306 | 0.56 | 3.0e-06 | Click! |
chr11_22005787_22005938 | Otx1 | 2965 | 0.333790 | 0.54 | 7.2e-06 | Click! |
chr11_22006313_22006464 | Otx1 | 3491 | 0.312436 | 0.54 | 8.3e-06 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_6883618_6884699 | 9.05 |
Gm13389 |
predicted gene 13389 |
112 |
0.85 |
chr4_122998794_122999794 | 7.14 |
Mycl |
v-myc avian myelocytomatosis viral oncogene lung carcinoma derived |
45 |
0.97 |
chrX_165326738_165328112 | 7.10 |
Glra2 |
glycine receptor, alpha 2 subunit |
32 |
0.99 |
chr13_83719687_83720586 | 6.98 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
1245 |
0.36 |
chr8_41054160_41054452 | 6.19 |
Mtus1 |
mitochondrial tumor suppressor 1 |
477 |
0.69 |
chr3_88206822_88208169 | 6.13 |
Gm3764 |
predicted gene 3764 |
183 |
0.86 |
chr14_39472202_39472383 | 5.54 |
Nrg3 |
neuregulin 3 |
374 |
0.93 |
chr9_22049418_22049658 | 5.52 |
Elavl3 |
ELAV like RNA binding protein 3 |
2472 |
0.12 |
chr1_177449667_177450314 | 5.25 |
Zbtb18 |
zinc finger and BTB domain containing 18 |
4169 |
0.18 |
chr3_88213113_88214199 | 5.20 |
Gm3764 |
predicted gene 3764 |
829 |
0.3 |
chr2_71525880_71527745 | 5.17 |
Dlx1as |
distal-less homeobox 1, antisense |
1107 |
0.33 |
chr13_84063384_84064052 | 5.12 |
Gm17750 |
predicted gene, 17750 |
1054 |
0.58 |
chr6_13835523_13837039 | 5.09 |
Gpr85 |
G protein-coupled receptor 85 |
960 |
0.59 |
chr12_29529828_29531185 | 4.87 |
Gm20208 |
predicted gene, 20208 |
609 |
0.74 |
chrX_147552308_147552607 | 4.86 |
Lrch2 |
leucine-rich repeats and calponin homology (CH) domain containing 2 |
1593 |
0.47 |
chr13_34125172_34126139 | 4.73 |
Tubb2b |
tubulin, beta 2B class IIB |
4699 |
0.12 |
chr13_42709240_42709536 | 4.72 |
Phactr1 |
phosphatase and actin regulator 1 |
155 |
0.97 |
chr1_166255711_166256817 | 4.63 |
Ildr2 |
immunoglobulin-like domain containing receptor 2 |
2071 |
0.3 |
chr2_83814030_83814462 | 4.62 |
Fam171b |
family with sequence similarity 171, member B |
1610 |
0.34 |
chr4_140245362_140247262 | 4.60 |
Igsf21 |
immunoglobulin superfamily, member 21 |
472 |
0.85 |
chrX_93292062_93292533 | 4.23 |
Arx |
aristaless related homeobox |
5787 |
0.25 |
chr3_17783692_17784517 | 4.20 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
5817 |
0.2 |
chr3_120982866_120983017 | 4.19 |
Gm43444 |
predicted gene 43444 |
37835 |
0.16 |
chrX_133682515_133683917 | 4.18 |
Pcdh19 |
protocadherin 19 |
1775 |
0.49 |
chr10_84757399_84758243 | 4.18 |
Rfx4 |
regulatory factor X, 4 (influences HLA class II expression) |
1759 |
0.41 |
chr12_49394720_49395481 | 4.09 |
3110039M20Rik |
RIKEN cDNA 3110039M20 gene |
4441 |
0.15 |
chrX_58033180_58034063 | 4.03 |
Zic3 |
zinc finger protein of the cerebellum 3 |
2611 |
0.36 |
chr8_54957303_54957776 | 3.90 |
Gm45263 |
predicted gene 45263 |
2280 |
0.24 |
chr3_34651759_34652037 | 3.77 |
Sox2 |
SRY (sex determining region Y)-box 2 |
1493 |
0.26 |
chr12_80759551_80760722 | 3.72 |
Ccdc177 |
coiled-coil domain containing 177 |
551 |
0.62 |
chr2_178143444_178143670 | 3.68 |
Phactr3 |
phosphatase and actin regulator 3 |
1624 |
0.46 |
chr7_51621596_51622924 | 3.68 |
Slc17a6 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 |
39 |
0.98 |
chr1_25832036_25832712 | 3.66 |
Gm9884 |
predicted gene 9884 |
1717 |
0.22 |
chr2_74426676_74427273 | 3.62 |
Lnpk |
lunapark, ER junction formation factor |
106132 |
0.05 |
chrX_110809955_110811467 | 3.57 |
Gm44593 |
predicted gene 44593 |
1613 |
0.43 |
chr9_4793004_4793465 | 3.52 |
Gria4 |
glutamate receptor, ionotropic, AMPA4 (alpha 4) |
2285 |
0.46 |
chr7_79501250_79502506 | 3.46 |
Mir9-3hg |
Mir9-3 host gene |
1757 |
0.18 |
chr1_64066352_64066608 | 3.42 |
Gm13748 |
predicted gene 13748 |
12174 |
0.19 |
chr18_31445651_31446131 | 3.41 |
Syt4 |
synaptotagmin IV |
1515 |
0.34 |
chr5_74676974_74677904 | 3.41 |
Lnx1 |
ligand of numb-protein X 1 |
190 |
0.94 |
chr2_105670519_105670670 | 3.34 |
Pax6os1 |
paired box 6 opposite strand 1 |
264 |
0.86 |
chr6_93911298_93911653 | 3.31 |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
1029 |
0.62 |
chrX_103184543_103184694 | 3.29 |
Nap1l2 |
nucleosome assembly protein 1-like 2 |
2022 |
0.23 |
chr15_71727296_71727625 | 3.25 |
Fam135b |
family with sequence similarity 135, member B |
378 |
0.89 |
chr8_8655111_8656501 | 3.21 |
Efnb2 |
ephrin B2 |
5433 |
0.1 |
chrX_165326400_165326667 | 3.20 |
Glra2 |
glycine receptor, alpha 2 subunit |
860 |
0.76 |
chr17_56241459_56242409 | 3.18 |
A230051N06Rik |
RIKEN cDNA A230051N06 gene |
218 |
0.81 |
chr15_44751938_44752279 | 3.18 |
A930017M01Rik |
RIKEN cDNA A930017M01 gene |
172 |
0.72 |
chrX_60890286_60890534 | 3.18 |
Sox3 |
SRY (sex determining region Y)-box 3 |
3020 |
0.21 |
chr1_64117867_64118702 | 3.14 |
Klf7 |
Kruppel-like factor 7 (ubiquitous) |
3198 |
0.25 |
chr3_76075976_76076354 | 3.13 |
Fstl5 |
follistatin-like 5 |
582 |
0.8 |
chr6_127133815_127134246 | 3.13 |
Ccnd2 |
cyclin D2 |
5122 |
0.12 |
chr18_31316134_31317386 | 3.13 |
Rit2 |
Ras-like without CAAX 2 |
351 |
0.9 |
chr14_76419153_76419898 | 3.07 |
Tsc22d1 |
TSC22 domain family, member 1 |
697 |
0.78 |
chr7_92984620_92985508 | 3.06 |
Gm31663 |
predicted gene, 31663 |
3012 |
0.25 |
chr3_118430889_118431675 | 3.06 |
Gm26871 |
predicted gene, 26871 |
958 |
0.44 |
chr3_63897818_63898430 | 3.03 |
Plch1 |
phospholipase C, eta 1 |
1249 |
0.38 |
chr2_172552598_172553073 | 3.00 |
Tfap2c |
transcription factor AP-2, gamma |
719 |
0.7 |
chrX_136591171_136591322 | 2.99 |
Tceal3 |
transcription elongation factor A (SII)-like 3 |
391 |
0.77 |
chr13_83984481_83985348 | 2.98 |
Gm4241 |
predicted gene 4241 |
3077 |
0.26 |
chr6_45062685_45062917 | 2.97 |
Cntnap2 |
contactin associated protein-like 2 |
2740 |
0.24 |
chr13_46975282_46975877 | 2.93 |
2010001K21Rik |
RIKEN cDNA 2010001K21 gene |
4329 |
0.13 |
chr5_111425949_111427685 | 2.93 |
Gm43119 |
predicted gene 43119 |
3228 |
0.22 |
chr8_65966341_65967718 | 2.92 |
Marchf1 |
membrane associated ring-CH-type finger 1 |
128 |
0.97 |
chr14_64575803_64576191 | 2.91 |
Mir124a-1hg |
Mir124-1 host gene (non-protein coding) |
11334 |
0.15 |
chr1_42709177_42709739 | 2.90 |
Pantr2 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 2 |
1406 |
0.34 |
chr6_103512786_103513033 | 2.87 |
Chl1 |
cell adhesion molecule L1-like |
1579 |
0.36 |
chr2_62089120_62089485 | 2.85 |
Slc4a10 |
solute carrier family 4, sodium bicarbonate cotransporter-like, member 10 |
42657 |
0.19 |
chr16_69469508_69470143 | 2.83 |
4930428D20Rik |
RIKEN cDNA 4930428D20 gene |
330556 |
0.01 |
chr11_111296170_111296792 | 2.83 |
Gm11675 |
predicted gene 11675 |
20381 |
0.29 |
chr8_99414293_99414856 | 2.82 |
Cdh8 |
cadherin 8 |
1745 |
0.36 |
chr6_121472423_121472626 | 2.80 |
Iqsec3 |
IQ motif and Sec7 domain 3 |
1099 |
0.53 |
chr16_77421091_77421970 | 2.79 |
9430053O09Rik |
RIKEN cDNA 9430053O09 gene |
290 |
0.84 |
chr3_17793835_17795104 | 2.78 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
427 |
0.75 |
chr4_27505050_27505757 | 2.78 |
Gm11901 |
predicted gene 11901 |
37775 |
0.23 |
chr1_172485277_172486996 | 2.77 |
Igsf9 |
immunoglobulin superfamily, member 9 |
3822 |
0.12 |
chr16_5887080_5887640 | 2.77 |
Rbfox1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
1773 |
0.51 |
chr11_88714836_88715643 | 2.75 |
Msi2 |
musashi RNA-binding protein 2 |
2862 |
0.23 |
chr5_142812883_142813172 | 2.75 |
Tnrc18 |
trinucleotide repeat containing 18 |
4353 |
0.21 |
chr2_180488104_180488754 | 2.75 |
Ntsr1 |
neurotensin receptor 1 |
11547 |
0.15 |
chr9_43070934_43071231 | 2.73 |
Arhgef12 |
Rho guanine nucleotide exchange factor (GEF) 12 |
28450 |
0.16 |
chrX_169829262_169829609 | 2.71 |
Mid1 |
midline 1 |
1276 |
0.55 |
chr2_158606690_158608449 | 2.69 |
Gm14204 |
predicted gene 14204 |
3021 |
0.15 |
chr18_77560767_77560987 | 2.68 |
Rnf165 |
ring finger protein 165 |
3732 |
0.27 |
chr18_80981812_80982477 | 2.66 |
Sall3 |
spalt like transcription factor 3 |
4392 |
0.15 |
chr10_84758414_84759491 | 2.62 |
Rfx4 |
regulatory factor X, 4 (influences HLA class II expression) |
2890 |
0.3 |
chr1_135372451_135373569 | 2.62 |
Shisa4 |
shisa family member 4 |
440 |
0.74 |
chr3_73056547_73057799 | 2.61 |
Slitrk3 |
SLIT and NTRK-like family, member 3 |
230 |
0.93 |
chr3_34653590_34654523 | 2.60 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
1980 |
0.2 |
chrX_135210129_135210918 | 2.59 |
Tceal6 |
transcription elongation factor A (SII)-like 6 |
164 |
0.93 |
chr16_16558986_16560577 | 2.58 |
Fgd4 |
FYVE, RhoGEF and PH domain containing 4 |
209 |
0.94 |
chr8_93813521_93813847 | 2.54 |
4930488L21Rik |
RIKEN cDNA 4930488L21 gene |
38 |
0.97 |
chr6_6861689_6861840 | 2.54 |
Dlx6os1 |
distal-less homeobox 6, opposite strand 1 |
173 |
0.9 |
chr14_79773410_79774519 | 2.52 |
Pcdh8 |
protocadherin 8 |
2652 |
0.21 |
chr15_87626925_87627959 | 2.52 |
Tafa5 |
TAFA chemokine like family member 5 |
2212 |
0.46 |
chr5_131534533_131535200 | 2.48 |
Auts2 |
autism susceptibility candidate 2 |
469 |
0.81 |
chr8_67817715_67818694 | 2.48 |
Psd3 |
pleckstrin and Sec7 domain containing 3 |
29 |
0.99 |
chr14_108912235_108913525 | 2.46 |
Slitrk1 |
SLIT and NTRK-like family, member 1 |
1278 |
0.64 |
chr14_64586889_64588168 | 2.45 |
Mir124a-1hg |
Mir124-1 host gene (non-protein coding) |
197 |
0.92 |
chr18_25752531_25753655 | 2.45 |
Celf4 |
CUGBP, Elav-like family member 4 |
401 |
0.88 |
chr14_122459815_122460898 | 2.44 |
Zic5 |
zinc finger protein of the cerebellum 5 |
335 |
0.81 |
chr18_43391464_43391742 | 2.43 |
Dpysl3 |
dihydropyrimidinase-like 3 |
1774 |
0.41 |
chr18_80984086_80984990 | 2.42 |
Sall3 |
spalt like transcription factor 3 |
1998 |
0.23 |
chr18_77564268_77564635 | 2.38 |
Rnf165 |
ring finger protein 165 |
158 |
0.96 |
chr10_59957195_59958780 | 2.38 |
Ddit4 |
DNA-damage-inducible transcript 4 |
6153 |
0.19 |
chr4_53633406_53634189 | 2.33 |
Fsd1l |
fibronectin type III and SPRY domain containing 1-like |
2081 |
0.3 |
chr2_163914378_163914944 | 2.32 |
Rims4 |
regulating synaptic membrane exocytosis 4 |
4022 |
0.23 |
chr2_42652202_42653456 | 2.31 |
Lrp1b |
low density lipoprotein-related protein 1B |
97 |
0.98 |
chr6_77247369_77247802 | 2.31 |
Lrrtm1 |
leucine rich repeat transmembrane neuronal 1 |
4663 |
0.29 |
chr4_91374442_91375761 | 2.30 |
Elavl2 |
ELAV like RNA binding protein 1 |
1206 |
0.41 |
chrX_93289773_93291216 | 2.29 |
Arx |
aristaless related homeobox |
3984 |
0.28 |
chr1_109986155_109986359 | 2.29 |
Cdh7 |
cadherin 7, type 2 |
2520 |
0.44 |
chr14_108909489_108909909 | 2.28 |
Slitrk1 |
SLIT and NTRK-like family, member 1 |
4459 |
0.37 |
chr3_5222045_5223052 | 2.28 |
Zfhx4 |
zinc finger homeodomain 4 |
1043 |
0.46 |
chr3_56181373_56181654 | 2.28 |
Nbea |
neurobeachin |
2188 |
0.32 |
chr19_14594521_14595178 | 2.28 |
Tle4 |
transducin-like enhancer of split 4 |
690 |
0.79 |
chrX_147552057_147552289 | 2.27 |
Lrch2 |
leucine-rich repeats and calponin homology (CH) domain containing 2 |
1877 |
0.42 |
chr13_99510773_99511921 | 2.26 |
Map1b |
microtubule-associated protein 1B |
5171 |
0.17 |
chr14_75457045_75457620 | 2.26 |
Siah3 |
siah E3 ubiquitin protein ligase family member 3 |
1350 |
0.5 |
chr17_10315220_10315427 | 2.25 |
Qk |
quaking |
4038 |
0.27 |
chr4_151103820_151105079 | 2.24 |
Camta1 |
calmodulin binding transcription activator 1 |
3854 |
0.22 |
chr12_98898102_98898513 | 2.23 |
Eml5 |
echinoderm microtubule associated protein like 5 |
2865 |
0.24 |
chr1_75263068_75263858 | 2.22 |
Ptprn |
protein tyrosine phosphatase, receptor type, N |
444 |
0.62 |
chr13_47843626_47844114 | 2.22 |
G630093K05Rik |
RIKEN cDNA G630093K05 gene |
66565 |
0.13 |
chrX_58020054_58020828 | 2.21 |
Zic3 |
zinc finger protein of the cerebellum 3 |
2259 |
0.37 |
chr17_62853514_62854199 | 2.21 |
Efna5 |
ephrin A5 |
27288 |
0.27 |
chr6_13834624_13835191 | 2.20 |
Gpr85 |
G protein-coupled receptor 85 |
2334 |
0.31 |
chr7_93082007_93082946 | 2.18 |
Gm9934 |
predicted gene 9934 |
1449 |
0.36 |
chr16_77645925_77646470 | 2.17 |
Mir125b-2 |
microRNA 125b-2 |
76 |
0.58 |
chr1_50925047_50926055 | 2.17 |
Tmeff2 |
transmembrane protein with EGF-like and two follistatin-like domains 2 |
1968 |
0.38 |
chr18_81178097_81178270 | 2.17 |
4930594M17Rik |
RIKEN cDNA 4930594M17 gene |
57883 |
0.12 |
chr10_120035094_120035766 | 2.16 |
Grip1 |
glutamate receptor interacting protein 1 |
42324 |
0.15 |
chrX_52914554_52915519 | 2.14 |
Phf6 |
PHD finger protein 6 |
2741 |
0.19 |
chr11_35873783_35874348 | 2.13 |
Wwc1 |
WW, C2 and coiled-coil domain containing 1 |
1647 |
0.4 |
chr4_25797148_25797299 | 2.13 |
Fut9 |
fucosyltransferase 9 |
2632 |
0.27 |
chr8_54956010_54956394 | 2.12 |
Gpm6a |
glycoprotein m6a |
1359 |
0.38 |
chr1_177640551_177640938 | 2.11 |
2310043L19Rik |
RIKEN cDNA 2310043L19 gene |
2199 |
0.28 |
chr13_39834675_39835074 | 2.10 |
A230103O09Rik |
RIKEN cDNA A230103O09 gene |
10491 |
0.16 |
chr16_81203792_81204456 | 2.09 |
Ncam2 |
neural cell adhesion molecule 2 |
3367 |
0.33 |
chr13_105249326_105250833 | 2.09 |
Rnf180 |
ring finger protein 180 |
20960 |
0.22 |
chr13_15570967_15571536 | 2.08 |
Gm48343 |
predicted gene, 48343 |
78684 |
0.09 |
chr4_102588865_102590254 | 2.05 |
Pde4b |
phosphodiesterase 4B, cAMP specific |
164 |
0.97 |
chr3_34104464_34105670 | 2.04 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
609 |
0.68 |
chr14_63585801_63587038 | 2.03 |
Xkr6 |
X-linked Kx blood group related 6 |
20084 |
0.15 |
chr11_84520959_84524590 | 2.03 |
Lhx1 |
LIM homeobox protein 1 |
63 |
0.97 |
chr13_84905458_84906287 | 2.03 |
Gm4059 |
predicted gene 4059 |
68445 |
0.12 |
chr9_113814888_113815428 | 2.02 |
Clasp2 |
CLIP associating protein 2 |
2558 |
0.32 |
chr1_177444257_177446079 | 2.02 |
Zbtb18 |
zinc finger and BTB domain containing 18 |
230 |
0.9 |
chr19_40832973_40833124 | 2.01 |
Ccnj |
cyclin J |
1740 |
0.34 |
chr15_68930024_68930460 | 2.01 |
Khdrbs3 |
KH domain containing, RNA binding, signal transduction associated 3 |
174 |
0.96 |
chr3_107114280_107114523 | 2.00 |
Kcna2 |
potassium voltage-gated channel, shaker-related subfamily, member 2 |
11719 |
0.15 |
chr4_11579073_11580188 | 1.99 |
Fsbp |
fibrinogen silencer binding protein |
35 |
0.97 |
chr6_55679226_55679709 | 1.97 |
Neurod6 |
neurogenic differentiation 6 |
1796 |
0.39 |
chr13_54887337_54888221 | 1.95 |
Gm29431 |
predicted gene 29431 |
309 |
0.86 |
chr8_49462071_49462635 | 1.95 |
4930555F03Rik |
RIKEN cDNA 4930555F03 gene |
970 |
0.52 |
chr19_28009042_28009226 | 1.94 |
Rfx3 |
regulatory factor X, 3 (influences HLA class II expression) |
1656 |
0.37 |
chr13_81630063_81630959 | 1.93 |
Adgrv1 |
adhesion G protein-coupled receptor V1 |
2628 |
0.28 |
chr2_158375202_158376961 | 1.93 |
Snhg11 |
small nucleolar RNA host gene 11 |
319 |
0.74 |
chr8_36548328_36549520 | 1.93 |
Dlc1 |
deleted in liver cancer 1 |
28345 |
0.19 |
chr7_140153197_140153943 | 1.92 |
Sprn |
shadow of prion protein |
29 |
0.95 |
chr14_76418527_76419086 | 1.92 |
Tsc22d1 |
TSC22 domain family, member 1 |
22 |
0.99 |
chr10_12612327_12612570 | 1.92 |
Utrn |
utrophin |
2383 |
0.42 |
chr3_34645483_34646017 | 1.92 |
Gm42692 |
predicted gene 42692 |
2486 |
0.17 |
chr11_54303826_54304909 | 1.92 |
Acsl6 |
acyl-CoA synthetase long-chain family member 6 |
165 |
0.94 |
chr8_47333763_47334279 | 1.90 |
Stox2 |
storkhead box 2 |
18327 |
0.23 |
chr2_172040251_172043672 | 1.90 |
Cbln4 |
cerebellin 4 precursor protein |
1505 |
0.35 |
chr3_88530342_88530859 | 1.89 |
Mex3a |
mex3 RNA binding family member A |
1795 |
0.15 |
chr9_100046462_100046656 | 1.88 |
4930519F24Rik |
RIKEN cDNA 4930519F24 gene |
22911 |
0.22 |
chr3_117359414_117360458 | 1.87 |
Plppr4 |
phospholipid phosphatase related 4 |
312 |
0.92 |
chr9_98032089_98032240 | 1.87 |
Clstn2 |
calsyntenin 2 |
819 |
0.69 |
chr14_12347237_12347663 | 1.86 |
Fezf2 |
Fez family zinc finger 2 |
739 |
0.55 |
chr15_20450538_20451616 | 1.85 |
Cdh12 |
cadherin 12 |
1812 |
0.3 |
chr2_13175207_13176270 | 1.85 |
Gm37780 |
predicted gene, 37780 |
12115 |
0.2 |
chr7_93082971_93083122 | 1.84 |
Gm9934 |
predicted gene 9934 |
2019 |
0.28 |
chr9_96731522_96733329 | 1.84 |
Zbtb38 |
zinc finger and BTB domain containing 38 |
244 |
0.91 |
chr9_29962949_29963397 | 1.84 |
Ntm |
neurotrimin |
32 |
0.99 |
chrX_135035488_135036479 | 1.84 |
3632454L22Rik |
RIKEN cDNA 3632454L22 gene |
165 |
0.95 |
chr3_102979790_102980444 | 1.83 |
Sike1 |
suppressor of IKBKE 1 |
15591 |
0.12 |
chr7_84528418_84529713 | 1.82 |
Gm2115 |
predicted gene 2115 |
73 |
0.97 |
chr5_7342376_7342862 | 1.80 |
Zfp804b |
zinc finger protein 804B |
2137 |
0.32 |
chr19_21788955_21789343 | 1.79 |
Cemip2 |
cell migration inducing hyaluronidase 2 |
10761 |
0.21 |
chr12_110187430_110189676 | 1.79 |
Gm34785 |
predicted gene, 34785 |
492 |
0.73 |
chr15_43869125_43870342 | 1.79 |
Tmem74 |
transmembrane protein 74 |
303 |
0.94 |
chr11_16257036_16258354 | 1.78 |
Vstm2a |
V-set and transmembrane domain containing 2A |
29 |
0.98 |
chr3_134302539_134303851 | 1.78 |
Gm43559 |
predicted gene 43559 |
30685 |
0.13 |
chr8_54959609_54959940 | 1.78 |
Gm45263 |
predicted gene 45263 |
45 |
0.97 |
chr8_12214009_12214733 | 1.77 |
A230072I06Rik |
RIKEN cDNA A230072I06 gene |
64448 |
0.1 |
chr2_134787470_134787766 | 1.76 |
Plcb1 |
phospholipase C, beta 1 |
1088 |
0.52 |
chr2_57613916_57615034 | 1.75 |
Gm13532 |
predicted gene 13532 |
14753 |
0.2 |
chrX_159459109_159459882 | 1.75 |
Map7d2 |
MAP7 domain containing 2 |
358 |
0.87 |
chr16_63860008_63860299 | 1.75 |
Epha3 |
Eph receptor A3 |
3260 |
0.37 |
chr16_94994610_94995225 | 1.74 |
Kcnj6 |
potassium inwardly-rectifying channel, subfamily J, member 6 |
2335 |
0.4 |
chr2_83812374_83813987 | 1.74 |
Fam171b |
family with sequence similarity 171, member B |
544 |
0.74 |
chr12_49390931_49392462 | 1.74 |
3110039M20Rik |
RIKEN cDNA 3110039M20 gene |
1037 |
0.42 |
chr10_34302326_34302666 | 1.73 |
Tspyl4 |
TSPY-like 4 |
3240 |
0.14 |
chr3_34646184_34646968 | 1.73 |
Gm42692 |
predicted gene 42692 |
3312 |
0.14 |
chr3_26152546_26153859 | 1.73 |
Nlgn1 |
neuroligin 1 |
105 |
0.98 |
chrX_152365298_152365450 | 1.73 |
3010001F23Rik |
RIKEN cDNA 3010001F23 gene |
3199 |
0.18 |
chr4_109155589_109157355 | 1.73 |
Osbpl9 |
oxysterol binding protein-like 9 |
138 |
0.97 |
chr8_89036575_89038609 | 1.72 |
Sall1 |
spalt like transcription factor 1 |
6570 |
0.23 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 10.3 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
1.2 | 10.7 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
1.0 | 2.9 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.8 | 3.4 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.8 | 7.4 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.8 | 2.5 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.8 | 2.4 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.8 | 2.4 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.7 | 2.2 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.7 | 2.8 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.7 | 2.8 | GO:0097107 | postsynaptic density organization(GO:0097106) postsynaptic density assembly(GO:0097107) |
0.7 | 2.7 | GO:0030035 | microspike assembly(GO:0030035) |
0.6 | 1.9 | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.6 | 3.0 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.6 | 1.7 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.6 | 1.7 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.5 | 2.7 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.5 | 2.7 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.5 | 2.7 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.5 | 1.0 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.5 | 2.0 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.5 | 1.0 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.5 | 1.5 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.5 | 2.4 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.5 | 1.4 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.5 | 1.4 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.4 | 1.3 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.4 | 1.2 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.4 | 2.0 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
0.4 | 0.4 | GO:0090493 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.4 | 1.5 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.4 | 0.8 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.4 | 1.1 | GO:0048880 | sensory system development(GO:0048880) |
0.4 | 0.7 | GO:1904023 | regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
0.3 | 3.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.3 | 3.1 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.3 | 1.0 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.3 | 1.0 | GO:0035935 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.3 | 2.0 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.3 | 1.0 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.3 | 3.2 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.3 | 0.9 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.3 | 0.9 | GO:0035696 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
0.3 | 1.2 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.3 | 1.2 | GO:0042891 | antibiotic transport(GO:0042891) |
0.3 | 1.4 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.3 | 2.0 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.3 | 0.9 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.3 | 0.6 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.3 | 0.3 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.3 | 0.8 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.3 | 2.1 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.3 | 1.0 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
0.3 | 0.5 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.3 | 5.4 | GO:0060384 | innervation(GO:0060384) |
0.3 | 1.0 | GO:0007296 | vitellogenesis(GO:0007296) |
0.3 | 0.8 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.3 | 1.3 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.2 | 0.5 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.2 | 0.7 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.2 | 4.2 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.2 | 1.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.2 | 0.7 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.2 | 0.7 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.2 | 0.7 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.2 | 0.7 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.2 | 1.4 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
0.2 | 0.2 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.2 | 4.9 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.2 | 0.7 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.2 | 0.4 | GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
0.2 | 1.3 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.2 | 0.4 | GO:1901536 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.2 | 0.7 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.2 | 0.2 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
0.2 | 0.6 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.2 | 2.1 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
0.2 | 0.4 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.2 | 2.1 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.2 | 0.4 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.2 | 0.6 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.2 | 1.8 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.2 | 0.6 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.2 | 0.4 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.2 | 0.6 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.2 | 0.6 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.2 | 0.4 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.2 | 0.8 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.2 | 0.2 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.2 | 3.2 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.2 | 0.4 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.2 | 0.4 | GO:0060166 | olfactory pit development(GO:0060166) |
0.2 | 0.2 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.2 | 0.9 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.2 | 0.9 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.2 | 0.5 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.2 | 0.7 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.2 | 0.4 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.2 | 10.8 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.2 | 1.0 | GO:0022605 | oogenesis stage(GO:0022605) |
0.2 | 0.5 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.2 | 0.3 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.2 | 0.5 | GO:0031223 | auditory behavior(GO:0031223) |
0.2 | 0.3 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.2 | 0.5 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.2 | 2.5 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 0.5 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 0.7 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.2 | 0.3 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.2 | 1.5 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.2 | 1.1 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.2 | 3.0 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.2 | 0.3 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.2 | 0.5 | GO:0071625 | vocalization behavior(GO:0071625) |
0.2 | 0.8 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.2 | 0.3 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.2 | 1.1 | GO:0097264 | self proteolysis(GO:0097264) |
0.2 | 0.6 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.2 | 0.5 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.2 | 0.5 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.2 | 0.8 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.1 | 0.4 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.3 | GO:0044849 | estrous cycle(GO:0044849) |
0.1 | 1.6 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.1 | 1.8 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.1 | 1.6 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.1 | 0.4 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 0.7 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.1 | 0.6 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.1 | 0.6 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 0.1 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
0.1 | 0.4 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.1 | 0.4 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.1 | 0.3 | GO:2000847 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.1 | 0.4 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.1 | 0.7 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.1 | 0.5 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 3.5 | GO:0021766 | hippocampus development(GO:0021766) |
0.1 | 0.3 | GO:0035482 | gastric motility(GO:0035482) |
0.1 | 10.3 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.1 | GO:0050883 | medulla oblongata development(GO:0021550) musculoskeletal movement, spinal reflex action(GO:0050883) |
0.1 | 0.8 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 0.4 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 0.4 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.1 | 0.1 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.1 | 0.5 | GO:0002681 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.1 | 0.2 | GO:0042706 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.1 | 0.5 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.1 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.1 | 0.5 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.1 | 0.5 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.7 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.1 | 0.4 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.1 | 0.4 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.1 | 0.4 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 0.2 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.1 | 0.8 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.1 | 0.4 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.1 | 1.2 | GO:0060074 | synapse maturation(GO:0060074) |
0.1 | 0.5 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.1 | 0.8 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.1 | 0.3 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.3 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.1 | 0.4 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.1 | 0.4 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 0.9 | GO:0033574 | response to testosterone(GO:0033574) |
0.1 | 0.4 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.1 | 0.6 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 0.2 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.1 | 0.1 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.1 | 0.8 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.1 | 0.3 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 0.2 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.1 | 0.3 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.1 | 0.7 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.1 | 0.5 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.1 | 0.4 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.1 | 0.2 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.1 | 0.4 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.3 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.1 | 0.3 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.1 | 1.6 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.2 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.1 | 0.3 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 0.2 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.1 | 0.9 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.1 | 0.6 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.6 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.1 | 0.4 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.1 | 0.6 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.1 | 0.4 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 2.1 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.3 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 0.3 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.1 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.1 | 0.7 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
0.1 | 0.3 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.1 | 0.3 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.1 | 0.7 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.3 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.1 | 1.5 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.1 | 0.3 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.1 | 0.8 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 | 0.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.2 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.1 | 0.3 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.1 | 0.2 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.1 | 0.7 | GO:0007616 | long-term memory(GO:0007616) |
0.1 | 0.4 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.1 | 0.2 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.1 | 0.2 | GO:0010963 | regulation of L-arginine import(GO:0010963) |
0.1 | 0.1 | GO:1901166 | neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
0.1 | 0.2 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.1 | 0.2 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.1 | 0.8 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 6.7 | GO:0007612 | learning(GO:0007612) |
0.1 | 0.9 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.2 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.1 | 0.3 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.1 | 0.3 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 0.4 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 1.9 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.1 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.1 | 0.2 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 0.2 | GO:2000109 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
0.1 | 1.9 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.1 | 0.5 | GO:0001964 | startle response(GO:0001964) |
0.1 | 0.6 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.1 | 0.8 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.1 | 0.1 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.1 | 0.6 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.1 | 3.2 | GO:0035773 | insulin secretion involved in cellular response to glucose stimulus(GO:0035773) |
0.1 | 1.8 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.2 | GO:0002278 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.1 | 0.1 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.1 | 0.5 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.1 | 0.1 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.1 | 0.1 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.1 | 1.0 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.1 | 0.4 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 0.5 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.3 | GO:0021854 | hypothalamus development(GO:0021854) |
0.1 | 0.5 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.1 | 0.6 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 0.3 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.1 | 0.4 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.1 | 0.7 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.3 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.1 | 0.5 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.1 | 0.3 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 0.1 | GO:1902075 | cellular response to salt(GO:1902075) |
0.1 | 0.1 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.1 | 0.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 0.2 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.1 | 0.5 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.1 | 0.1 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) positive regulation of glucose mediated signaling pathway(GO:1902661) |
0.1 | 0.2 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.1 | GO:0061196 | fungiform papilla development(GO:0061196) |
0.1 | 0.2 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.3 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.1 | 1.7 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.1 | 0.2 | GO:0032202 | telomere assembly(GO:0032202) |
0.1 | 0.2 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.1 | 0.5 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.1 | 0.3 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.1 | 0.3 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.3 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.2 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.1 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.1 | 0.3 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.1 | 0.4 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.1 | 0.1 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.1 | 0.2 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.1 | 0.3 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.1 | 0.1 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.1 | 0.6 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.1 | 1.4 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 0.1 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.1 | 0.4 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.1 | 0.1 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 1.4 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.1 | 0.9 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 0.2 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.1 | 0.1 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.1 | 0.2 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.1 | 0.3 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.1 | 0.6 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.1 | 0.1 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.1 | 0.2 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.1 | 0.2 | GO:0003139 | secondary heart field specification(GO:0003139) |
0.1 | 0.6 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 0.1 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.1 | 0.2 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.1 | 0.1 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.1 | 0.1 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.1 | 0.8 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
0.1 | 0.2 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.1 | 0.4 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.1 | 0.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.2 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.0 | 0.7 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.0 | 0.1 | GO:0090135 | actin filament branching(GO:0090135) |
0.0 | 0.2 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.0 | 0.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 0.2 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.0 | 0.3 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.0 | 0.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.0 | 0.6 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.1 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.0 | 1.4 | GO:0003407 | neural retina development(GO:0003407) |
0.0 | 0.4 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.0 | 0.4 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 0.0 | GO:0051231 | spindle elongation(GO:0051231) |
0.0 | 0.2 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.0 | 0.1 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.0 | 0.5 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.0 | 0.1 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.0 | 0.2 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.0 | 0.1 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.0 | 0.1 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.0 | 0.3 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.1 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.0 | 0.2 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.0 | 0.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.0 | 0.5 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.0 | 0.5 | GO:0036065 | fucosylation(GO:0036065) |
0.0 | 0.2 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.0 | 0.1 | GO:0009642 | response to light intensity(GO:0009642) |
0.0 | 0.0 | GO:0015810 | aspartate transport(GO:0015810) |
0.0 | 0.1 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.0 | 0.2 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.0 | 0.0 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) |
0.0 | 0.1 | GO:0002606 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.0 | 0.1 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.0 | 0.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 0.0 | GO:0002434 | immune complex clearance(GO:0002434) |
0.0 | 0.2 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.0 | 0.3 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 0.2 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.0 | 0.3 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.4 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.0 | 0.0 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.0 | 0.0 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
0.0 | 0.1 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.0 | 0.4 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.0 | 0.1 | GO:0002254 | kinin cascade(GO:0002254) |
0.0 | 0.1 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.0 | 0.3 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.0 | 0.1 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.0 | 0.0 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.0 | 0.0 | GO:0014719 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) skeletal muscle satellite cell activation(GO:0014719) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.0 | 0.2 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.0 | 0.3 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.1 | GO:0014028 | notochord formation(GO:0014028) |
0.0 | 0.2 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.0 | 0.0 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.0 | 0.1 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.1 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.0 | 0.5 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 0.1 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.0 | 0.1 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.0 | 0.2 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.0 | 0.4 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.1 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.0 | 0.3 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 0.0 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.0 | 0.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.5 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.1 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.0 | 0.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.4 | GO:0001967 | suckling behavior(GO:0001967) |
0.0 | 0.1 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.0 | 0.1 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.0 | 0.1 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.0 | 0.1 | GO:0070842 | aggresome assembly(GO:0070842) |
0.0 | 0.1 | GO:0097503 | sialylation(GO:0097503) |
0.0 | 0.4 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.0 | 0.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.0 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.0 | 0.2 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.1 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.0 | 0.3 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.0 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.0 | 0.1 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.0 | 0.2 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.0 | 0.1 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.0 | 0.0 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) |
0.0 | 0.3 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.0 | 0.1 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.0 | 0.2 | GO:0033280 | response to vitamin D(GO:0033280) |
0.0 | 0.1 | GO:0035425 | autocrine signaling(GO:0035425) |
0.0 | 0.0 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.0 | 0.6 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.1 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.0 | 0.1 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.0 | 0.2 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.0 | 0.1 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.0 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.0 | 0.1 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.0 | 0.1 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.2 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) |
0.0 | 0.5 | GO:0097186 | amelogenesis(GO:0097186) |
0.0 | 0.2 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.0 | 0.7 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.2 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.0 | 0.1 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.0 | 0.1 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.0 | 0.1 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.0 | 0.1 | GO:0008354 | germ cell migration(GO:0008354) |
0.0 | 0.1 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.0 | 0.2 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.0 | 0.1 | GO:0072393 | minus-end-directed organelle transport along microtubule(GO:0072385) microtubule anchoring at microtubule organizing center(GO:0072393) |
0.0 | 0.1 | GO:0055059 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) asymmetric neuroblast division(GO:0055059) |
0.0 | 0.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.1 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.0 | 0.4 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.0 | 0.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.0 | 0.1 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.0 | 0.4 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.0 | 0.4 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.0 | 0.1 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.0 | 0.1 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.1 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.0 | 0.1 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.0 | 0.1 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.0 | 0.3 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.0 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.0 | 0.2 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.0 | 0.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.0 | 0.0 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.0 | 0.1 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.0 | 0.1 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.0 | 0.0 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.0 | 0.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.0 | 0.1 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.0 | 0.2 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.0 | 0.1 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.0 | 0.1 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.0 | 0.3 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.0 | 0.0 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.0 | 0.1 | GO:0034627 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.2 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.0 | 0.0 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.2 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.0 | 0.3 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.1 | GO:1904751 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.0 | 0.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.1 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
0.0 | 0.1 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.0 | 0.0 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.0 | 0.0 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.0 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.0 | 0.0 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.0 | 0.0 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.0 | 0.2 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.1 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.0 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.1 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.1 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.0 | 0.0 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.0 | 0.7 | GO:0051193 | regulation of cofactor metabolic process(GO:0051193) |
0.0 | 0.1 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.0 | 0.1 | GO:0015879 | carnitine transport(GO:0015879) |
0.0 | 0.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.0 | 0.0 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.0 | 0.1 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.0 | 0.1 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.0 | 0.1 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.0 | 0.2 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.0 | 0.2 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.0 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.0 | 0.1 | GO:0009838 | abscission(GO:0009838) |
0.0 | 0.0 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.0 | 0.0 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.0 | 0.4 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
0.0 | 0.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 0.0 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.0 | 0.0 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.0 | 0.0 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.0 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.0 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.0 | 0.2 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.0 | 0.0 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.0 | 0.1 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.0 | 0.1 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.0 | 0.1 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.0 | 0.0 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.0 | 0.7 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.0 | GO:0046036 | CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) |
0.0 | 0.1 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.0 | 0.1 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.0 | 0.3 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.0 | 0.0 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.0 | 0.0 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.0 | 0.0 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.1 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.0 | 0.1 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.2 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.0 | 0.1 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 0.0 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.0 | 0.1 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.0 | 0.0 | GO:0061526 | acetylcholine secretion(GO:0061526) |
0.0 | 0.0 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) positive regulation of osteoclast proliferation(GO:0090290) |
0.0 | 0.2 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.0 | 0.1 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.0 | 0.1 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.0 | 0.2 | GO:0006415 | translational termination(GO:0006415) |
0.0 | 0.2 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.0 | 0.0 | GO:0040031 | snRNA modification(GO:0040031) |
0.0 | 0.1 | GO:0070849 | response to epidermal growth factor(GO:0070849) |
0.0 | 0.0 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.0 | 0.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.2 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.0 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.1 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.5 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.1 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.1 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.0 | 0.0 | GO:0100012 | regulation of heart induction by regulation of canonical Wnt signaling pathway(GO:0090081) regulation of heart induction by canonical Wnt signaling pathway(GO:0100012) |
0.0 | 0.0 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.0 | 0.0 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.0 | 0.0 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.0 | 0.1 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.0 | 0.0 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.0 | 0.1 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.0 | 0.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.0 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.0 | 0.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.0 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.0 | 0.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 0.0 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.0 | 0.0 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.0 | 0.1 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.1 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.0 | 0.0 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.0 | 0.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.0 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
0.0 | 0.0 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.0 | 0.3 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.0 | 0.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.0 | 0.0 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.0 | 0.0 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.0 | 0.0 | GO:0003383 | apical constriction(GO:0003383) |
0.0 | 0.0 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.0 | 0.0 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.0 | 0.0 | GO:0043633 | polyadenylation-dependent RNA catabolic process(GO:0043633) nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.0 | 0.0 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.0 | 0.0 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.0 | 0.1 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.1 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
0.0 | 0.2 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.0 | 0.1 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.0 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.0 | 0.1 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.0 | 0.1 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.1 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.0 | 0.1 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.0 | 0.1 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.0 | 0.1 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.0 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.0 | 0.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.1 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.0 | 0.0 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.0 | 0.0 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.0 | 0.1 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.0 | 0.0 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.0 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.0 | 0.1 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.0 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.0 | 0.0 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.0 | 0.1 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.0 | 0.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.0 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.0 | 0.1 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.0 | 0.0 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.0 | 0.1 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.0 | 0.0 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.0 | 0.0 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.0 | 0.0 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.0 | 0.0 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.0 | 0.0 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.0 | 0.1 | GO:0021696 | cerebellar cortex morphogenesis(GO:0021696) |
0.0 | 0.0 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.0 | 0.0 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.0 | 0.0 | GO:0071027 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.0 | 0.0 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.0 | 0.2 | GO:0060359 | response to ammonium ion(GO:0060359) |
0.0 | 0.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.0 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.0 | 0.1 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
0.0 | 0.1 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 0.2 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.1 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.1 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.0 | GO:0002339 | B cell selection(GO:0002339) |
0.0 | 0.0 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.0 | 0.1 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.0 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.0 | 0.1 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.0 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.0 | 0.0 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 4.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.5 | 3.5 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.5 | 2.3 | GO:0097433 | dense body(GO:0097433) |
0.4 | 3.4 | GO:0043083 | synaptic cleft(GO:0043083) |
0.4 | 1.7 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.4 | 1.1 | GO:0097441 | basilar dendrite(GO:0097441) |
0.4 | 1.8 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.3 | 1.0 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.3 | 5.2 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.3 | 1.7 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.3 | 10.5 | GO:0034707 | chloride channel complex(GO:0034707) |
0.3 | 2.5 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.2 | 0.7 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.2 | 1.8 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 0.4 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.2 | 6.4 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.2 | 2.2 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 0.5 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.2 | 0.5 | GO:0097513 | myosin II filament(GO:0097513) |
0.2 | 1.9 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.2 | 0.5 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.1 | 0.4 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 2.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 1.1 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.3 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.1 | 1.0 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 0.6 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.3 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 2.9 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 0.4 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 1.5 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.4 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.7 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.8 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 0.7 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 1.6 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.4 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.1 | 2.4 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 0.5 | GO:0000235 | astral microtubule(GO:0000235) |
0.1 | 0.7 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.5 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.8 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 0.9 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 0.5 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 0.6 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.1 | 0.8 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 1.0 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 3.5 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 0.2 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.1 | 0.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 2.3 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 0.7 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.3 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 1.3 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 0.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 0.6 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 0.3 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 0.6 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.5 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 9.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.7 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.5 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 1.0 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 0.3 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 0.2 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 0.2 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.1 | GO:0043219 | lateral loop(GO:0043219) |
0.1 | 0.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 0.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 0.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.1 | 8.8 | GO:0097060 | synaptic membrane(GO:0097060) |
0.1 | 0.6 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 0.1 | GO:0051286 | cell tip(GO:0051286) |
0.1 | 0.1 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.3 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 0.2 | GO:0000802 | transverse filament(GO:0000802) |
0.1 | 0.3 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 0.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 1.8 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 0.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.7 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.1 | 0.4 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 0.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 0.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.2 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.0 | 0.2 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 0.2 | GO:0097452 | GAIT complex(GO:0097452) |
0.0 | 0.4 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.4 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.8 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.0 | 0.1 | GO:0033010 | paranodal junction(GO:0033010) |
0.0 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.5 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.2 | GO:0042825 | TAP complex(GO:0042825) |
0.0 | 3.0 | GO:0030427 | site of polarized growth(GO:0030427) |
0.0 | 0.1 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 0.5 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 0.6 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.2 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.0 | 0.2 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.0 | 0.6 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.4 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.5 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.0 | 0.2 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.3 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.0 | 1.4 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 0.1 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.0 | 0.1 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.0 | 2.4 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.0 | 0.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 1.4 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.6 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 0.0 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.0 | 0.4 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.9 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.0 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.0 | 0.0 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.0 | 0.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 0.2 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 0.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.0 | 0.3 | GO:0031256 | leading edge membrane(GO:0031256) |
0.0 | 0.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.0 | 0.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 0.1 | GO:0044292 | dendrite terminus(GO:0044292) |
0.0 | 0.1 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.0 | 0.1 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 0.5 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.2 | GO:0070187 | telosome(GO:0070187) |
0.0 | 0.2 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 0.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.0 | 0.1 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.1 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.4 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.0 | 0.2 | GO:0005687 | U4 snRNP(GO:0005687) |
0.0 | 0.1 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.1 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 0.2 | GO:0061702 | inflammasome complex(GO:0061702) |
0.0 | 0.1 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 0.3 | GO:0001741 | XY body(GO:0001741) |
0.0 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.1 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 1.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.1 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.0 | 0.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.1 | GO:1990423 | RZZ complex(GO:1990423) |
0.0 | 1.2 | GO:0043679 | axon terminus(GO:0043679) |
0.0 | 0.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.0 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.0 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.0 | GO:0042827 | platelet dense granule(GO:0042827) |
0.0 | 0.1 | GO:0097255 | R2TP complex(GO:0097255) |
0.0 | 0.1 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.7 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.0 | GO:0072534 | perineuronal net(GO:0072534) |
0.0 | 0.7 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.1 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.1 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.0 | 0.1 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.2 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.0 | 0.2 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 1.1 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.1 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.0 | 0.0 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.0 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 0.0 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 0.3 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 0.0 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.0 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.0 | 0.2 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 1.1 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.0 | 0.1 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.0 | 0.0 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.0 | 0.0 | GO:0016939 | kinesin II complex(GO:0016939) |
0.0 | 3.1 | GO:0045202 | synapse(GO:0045202) |
0.0 | 0.1 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 1.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.1 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.0 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.0 | 0.0 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.0 | 0.1 | GO:0005652 | nuclear lamina(GO:0005652) |
0.0 | 0.3 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.0 | GO:0005712 | chiasma(GO:0005712) |
0.0 | 0.1 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 0.1 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.0 | 0.0 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.0 | 0.1 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 0.0 | GO:0044194 | cytolytic granule(GO:0044194) |
0.0 | 0.0 | GO:0044308 | axonal spine(GO:0044308) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 10.4 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
1.0 | 7.8 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.7 | 2.2 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.7 | 2.8 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.6 | 2.6 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.5 | 1.6 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.5 | 3.6 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.5 | 1.5 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.5 | 1.5 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.5 | 1.4 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.5 | 5.5 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.5 | 0.5 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.5 | 2.7 | GO:0048495 | Roundabout binding(GO:0048495) |
0.4 | 1.2 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.4 | 1.2 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.4 | 1.2 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.4 | 1.9 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.4 | 3.4 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.3 | 8.6 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.3 | 1.4 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.3 | 0.9 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.3 | 1.1 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.3 | 2.5 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.3 | 1.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.3 | 1.0 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.3 | 1.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 0.7 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.2 | 0.7 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.2 | 4.6 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.2 | 2.4 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 5.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 1.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.2 | 1.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.2 | 1.0 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.2 | 0.6 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.2 | 1.6 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.2 | 1.1 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.2 | 1.9 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.2 | 0.7 | GO:0004083 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) |
0.2 | 0.5 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.2 | 2.9 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 0.5 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 1.0 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 0.5 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.2 | 0.5 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.2 | 0.6 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.2 | 0.5 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 1.9 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.9 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.3 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.1 | 0.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.7 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.1 | 0.5 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.1 | 2.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.4 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.1 | 0.5 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.4 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.1 | 2.9 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 2.1 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.6 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 1.4 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 1.1 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.1 | 0.4 | GO:0046428 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.1 | 0.5 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.6 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.5 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 0.5 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 2.0 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.5 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.1 | 0.5 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 0.4 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 0.3 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 0.3 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.1 | 0.3 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.1 | 1.6 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.3 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.1 | 0.1 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.1 | 0.3 | GO:0070905 | serine binding(GO:0070905) |
0.1 | 0.5 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.1 | 0.3 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 0.4 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 0.3 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.4 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.1 | 1.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.4 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.1 | 0.6 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 1.4 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.1 | 0.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 0.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 0.3 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.1 | 0.2 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 0.2 | GO:0050692 | DBD domain binding(GO:0050692) |
0.1 | 0.5 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 1.9 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.5 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 2.3 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.2 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.1 | 0.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.1 | GO:0001032 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.1 | 0.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.1 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 1.1 | GO:0031402 | sodium ion binding(GO:0031402) |
0.1 | 0.2 | GO:1990188 | euchromatin binding(GO:1990188) |
0.1 | 0.2 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.4 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.1 | 0.4 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.1 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 1.4 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.1 | 0.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 0.7 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.3 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.5 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.1 | 0.8 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.4 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.1 | 0.6 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 0.6 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 0.3 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.1 | 0.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.3 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 0.2 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 0.2 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.1 | 0.2 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 0.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.3 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.4 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.3 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.1 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.1 | 0.3 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 1.4 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.3 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 0.9 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 0.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.5 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 0.2 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.0 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 0.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.5 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.2 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.0 | 0.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.0 | 0.0 | GO:0035197 | siRNA binding(GO:0035197) |
0.0 | 0.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.9 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.3 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 0.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.0 | 0.2 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.0 | 0.1 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.0 | 1.7 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.1 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.0 | 0.1 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.0 | 0.0 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.0 | 0.0 | GO:0015172 | acidic amino acid transmembrane transporter activity(GO:0015172) |
0.0 | 0.4 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 0.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.3 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.0 | 0.6 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.0 | 0.6 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 0.8 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.2 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.0 | 0.4 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.3 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.0 | 0.7 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.2 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.0 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.0 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.0 | 0.2 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.2 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.0 | 0.2 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.0 | 0.1 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.0 | GO:0004673 | protein histidine kinase activity(GO:0004673) phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.0 | 0.0 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.0 | 0.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.3 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.4 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.2 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 0.1 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.0 | 0.1 | GO:0030519 | snoRNP binding(GO:0030519) |
0.0 | 0.1 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.0 | 0.5 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 2.0 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.0 | 0.2 | GO:0034046 | poly(G) binding(GO:0034046) |
0.0 | 0.0 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.0 | 0.4 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.0 | 0.3 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.1 | GO:0071253 | connexin binding(GO:0071253) |
0.0 | 0.2 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.7 | GO:0033558 | protein deacetylase activity(GO:0033558) |
0.0 | 0.3 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.0 | 0.4 | GO:0048038 | quinone binding(GO:0048038) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 2.1 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.1 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.0 | 0.4 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 1.2 | GO:0022843 | voltage-gated cation channel activity(GO:0022843) |
0.0 | 0.1 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.0 | 0.1 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.0 | 0.0 | GO:0019959 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
0.0 | 0.2 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.1 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.0 | 0.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.2 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.1 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.2 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.0 | 0.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.0 | 0.5 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.1 | GO:0035939 | microsatellite binding(GO:0035939) |
0.0 | 0.5 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.0 | 0.2 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.0 | 0.3 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 2.4 | GO:0005516 | calmodulin binding(GO:0005516) |
0.0 | 0.1 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.5 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.4 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.6 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.0 | 0.4 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.0 | 0.8 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.0 | 2.5 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.0 | 0.1 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 0.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.0 | 0.1 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.0 | 0.1 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.0 | 0.5 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.0 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.0 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.0 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.1 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.0 | 0.0 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.0 | 0.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.0 | 0.1 | GO:0070061 | fructose binding(GO:0070061) |
0.0 | 0.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.0 | GO:0009374 | biotin binding(GO:0009374) |
0.0 | 0.1 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.0 | 0.3 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.1 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 0.1 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.0 | 0.0 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.1 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.0 | 0.1 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.0 | 0.2 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.1 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.0 | 0.1 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.0 | 0.2 | GO:0051378 | serotonin binding(GO:0051378) |
0.0 | 0.1 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.0 | 2.1 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.1 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.0 | 0.1 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.2 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.1 | GO:0016594 | glycine binding(GO:0016594) |
0.0 | 1.0 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.0 | 0.1 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.0 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.1 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 0.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.3 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.0 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.1 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.0 | 0.0 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.1 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.1 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.0 | 0.0 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.0 | 0.1 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 0.1 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.0 | 0.0 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.0 | 0.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.0 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.0 | 0.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.7 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.0 | 0.3 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.0 | 0.1 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.1 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.0 | 0.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.1 | GO:0097001 | ceramide binding(GO:0097001) |
0.0 | 0.0 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.0 | 0.1 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.0 | 0.0 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.1 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 0.1 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 0.0 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.0 | 0.1 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.1 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.0 | 0.0 | GO:0043398 | HLH domain binding(GO:0043398) |
0.0 | 0.0 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.0 | 0.0 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.0 | 0.0 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 0.2 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.0 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.0 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.0 | 1.3 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.0 | 0.4 | GO:0004527 | exonuclease activity(GO:0004527) |
0.0 | 0.0 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.0 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 5.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 3.9 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 4.4 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 3.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 0.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 1.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 2.6 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 0.5 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 1.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 2.3 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 2.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 1.5 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 1.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.7 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 1.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 4.8 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 3.0 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 1.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 0.9 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 0.9 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.9 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.9 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 1.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.4 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.9 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.2 | ST STAT3 PATHWAY | STAT3 Pathway |
0.0 | 0.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.5 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.4 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 0.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.5 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.0 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 0.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.6 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.1 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.2 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.1 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.2 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.1 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.0 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.3 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 13.7 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.3 | 0.3 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.3 | 3.8 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.2 | 3.1 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.2 | 5.3 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.2 | 3.0 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.2 | 2.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.2 | 3.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 2.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 2.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 0.6 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.1 | 1.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 5.3 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.1 | 1.6 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 2.3 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 0.2 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 1.3 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 1.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 0.5 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 3.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 0.6 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 0.9 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 0.8 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 1.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 1.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 1.5 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 0.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 0.2 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 0.1 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 0.6 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 1.0 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 1.2 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 1.0 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 0.9 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.1 | 0.4 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 0.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 0.1 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.1 | 0.1 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.1 | 0.3 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.0 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 0.2 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.0 | 0.5 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.2 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.1 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.0 | 0.4 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 1.2 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.0 | 0.4 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.5 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.0 | 0.0 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.0 | 0.3 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 0.2 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.4 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 0.2 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.0 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.0 | 0.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.8 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.2 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.0 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.7 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.0 | 0.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.0 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.4 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.0 | 0.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 1.4 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
0.0 | 0.4 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.0 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
0.0 | 0.2 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 0.4 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.1 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.0 | 0.1 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 0.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.1 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.0 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.0 | 0.7 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.0 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.0 | 0.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.0 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |